Login / Signup

From viability to cell death: Claims with insufficient evidence in high-impact cell culture studies.

Ali Burak ÖzkayaCaner Geyik
Published in: PloS one (2022)
Our analysis revealed a discordance between experimental findings and the way they were presented and discussed in the manuscripts. To improve quality of pre-clinical research, we require clear nomenclature by which different cell culture claims are distinctively categorized; materials and methods sections to be written more meticulously; and cell culture methods to be selected and utilized more carefully. In this paper we recommend a nomenclature for selected cell culture claims as well as a methodology for collecting evidence to support those claims.
Keyphrases
  • health insurance
  • cell death
  • single cell
  • quality improvement
  • signaling pathway